PotNetwork Holding Inc. (POTN) Remains a Strong Performer

New Post Public Reply Private Reply Replies (1) Message Board
NetworkNewsWire
829
PotNetwork Holding Inc. (POTN) Remains a Strong Performer in an Expanding Market

- CBD market is set to reach or exceed $1.8 billion by 2020
- PotNetwork Holdings’ sales jumped 30 percent from June to July
- Subsidiary Diamond CBD distributes products to 10,000+ stores in 50 states

The future for the cannabidiol (CBD) market remains bright. Brightfield Group recently projected hemp-derived cannabidiol to become a billion-dollar market by 2020, given a current compound annual growth rate of 55 percent (http://nnw.fm/rDmb5). PotNetwork Holding Inc. (OTC: POTN) recently published estimates by Hemp Business Journal (http://nnw.fm/7QKvg) suggesting that hemp-based CBD will be a $1.8 billion market by 2020. PotNetwork Holding, the holding company for Diamond CBD, has been quite active and dominant in the market and projects that the industry will exceed $2.1 billion by then. Diamond CBD has enjoyed success with its 15+ CBD brands and distribution network of more than 10,000 stores selling its products. SeeThruEquity, LLC has projected POTN to exceed $30 million in revenue by FY2019.

PotNetwork Holding has experienced rapid sales growth, jumping 30 percent from June to July, when it reported $1,459,137 in sales. For the first six months of FY2017, it reported sales volume in excess of $5 million, marking a 178 percent year-over-year increase in revenue. The company also sold $820,000 in products at three recent trade shows – CHAMPS, the BIG Industry Trade Show and the Market Week Event. This past August, it saw success at BIG, where it sold more than $200,000 in merchandise at the New York event featuring manufacturers, distributors, wholesalers and store owners.

Diamond CBD, owned by POTN subsidiary First Capital Venture Co., has been expanding from marketing and distribution to more research and development for various premium hemp extracts. These contain a range of different cannabinoids. The emphasis is on natural CBD ingredients and production using a carefully monitored process. Products range from delicious Diamond CBD Gummies to CBD Double Shots squeezable packages, Chill Pill CBD infused capsules and more than 300 flavored hemp oils produced by the company.

The hemp-based cannabinoid extracts marketed by Diamond CBD, in addition to edibles, vapes and creams, among other items, has become a significant force in the smoke/vape shop industry. In addition, its products are distributed and sold in 50 states. This nationwide presence is possible, because the U.S. Food and Drug Administration does not restrict the use of hemp-derived extracts from imported industrial hemp plants as it does with marijuana and industrial hemp plants grown within the U.S. However, growing these plants is now legal in South Carolina and Arizona, while other states are also easing restrictions.

Recent corporate changes have paid off for PotNetwork Holdings. In July 2015, it changed its name from United Treatment Centres Inc., and has been under the leadership of Gary Blum since January 2016. POTN acquired First Capital Venture Co. and Diamond CBD Inc. in January 2017. Its business focus is now solely on the U.S. and international CBD market, which represent a combined consumer base of about 1.5 billion. According to the U.S. National Library of Medicine National Institutes of Health, products based on CBD oil include therapeutic, homeopathic and natural remedies for addressing stress, anxiety, sleep disorders and a range of other ailments and illnesses.

For more information, visit the company’s website at www.PotNetworkHolding.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Potnetwork Holdings, Inc. (POTN) Stock Research Links

POTN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading

Top 5 Most Recently Viewed Articles

NVIDIA and Synopsys Forge Alliance to Transform Engineering

Updated Category News Views 137

Strategic Collaboration Between NVIDIA and Synopsys In an exciting development for the engineering and design industries, NVIDIA and Synopsys have joined forces in a strategic partnership that promises to revolutionize how these sectors operate. This collaboration aims to leverage NVIDIA's powerful computational capabilities alongside Synopsys' sophisticated engineering...

Continue Reading
EHang's Groundbreaking Pilotless Flight Marks a Historic Event

Updated Category News Views 110

EHang's Historic Pilotless Flight in Africa EHang Holdings Limited (Nasdaq: EH), a frontrunner in Urban Air Mobility (UAM), has made headlines by achieving a remarkable milestone: the first pilotless human-carrying flight of its EH216-S eVTOL aircraft in Africa. This significant event unfolded at the 9th Aviation Africa Summit in Kigali, marking a historic moment for the...

Continue Reading
Bang & Olufsen's Share Buyback: Strategic Moves for Growth

Updated Category News Views 112

Understanding Bang & Olufsen's Share Buyback Program Bang & Olufsen A/S has embarked on a significant initiative aimed at bolstering its long-term growth through its recent share buyback program. This strategic move is designed to hedge the company’s share-based long-term incentive programmes, showcasing their commitment to enhancing shareholder value. This article...

Continue Reading
Johnson & Johnson's Q2 Expectations and Analyst Ratings Insights

Updated Category News Views 275

Upcoming Earnings Announcement for Johnson & Johnson Johnson & Johnson (NYSE: JNJ) is preparing to disclose its earnings results for the upcoming second quarter. Analysts are closely watching the anticipated report, which is expected to provide valuable insights into the company's financial health. Expected Financial Performance Analyst forecasts suggest that Johnson &...

Continue Reading
Safe House Project Expands Impact with ATI Acquisition

Updated Category News Views 307

Safe House Project Expands Impact with ATI Acquisition This Giving Tuesday, the Safe House Project (SHP) shared exciting news about its acquisition of Anti-Trafficking International (ATI), an organization that has been pivotal in the fight against human trafficking. By incorporating ATI's respected practices and its renowned Just Ask Prevention Curriculum, SHP aims to...

Continue Reading